Strate Labs Is Closing: What Happened and the Safe Alternative (2026)
Strate Labs posted a sitewide notice that it is closing in 2026, with clearance discounts across its catalog. If you relied on them, here is what changed and the prescribed, pharmacy-grade path that does not vanish.
If you are looking for a Strate Labs alternative, here is why: Strate Labs, a research-use-only peptide vendor, posted a sitewide notice on stratelabs.com that it is closing in 2026, with clearance discounts across its catalog. Its statement cited a regulatory landscape that shifted in ways that made it impossible to keep operating with its prior quality, transparency, and integrity.
This guide lays out the verified facts of what happened, why a research-use-only vendor with no prescriber and no licensed pharmacy is fragile by design, and the safe way forward: a prescribed, pharmacy-grade path where a licensed physician prescribes, an FDA-registered 503A pharmacy compounds, a Certificate of Analysis verifies each batch, and pru prices the peptide at cost. pru is built only for that path and it does not vanish.
Strate Labs is closing in 2026, and here is the safe alternative
Strate Labs, a research-use-only peptide vendor, posted a sitewide notice that it is closing in 2026, with clearance discounts across its catalog, its statement citing a regulatory landscape that shifted in ways that made it impossible to keep operating with its prior quality, transparency, and integrity. The safe alternative is not another research-use-only site selling vials labeled for laboratory use.
It is a prescribed, pharmacy-grade path: the same kinds of peptides, but ordered through a licensed telehealth provider where a physician confirms the peptide is appropriate for you and a 503A pharmacy fills it with a Certificate of Analysis. That is the entire difference between a research chemical that can disappear and a medicine you can stand behind.
THE ONE LINE THAT MATTERSA vendor with no prescriber, no licensed pharmacy, and no accountability can close its doors and take your source with it. A prescribed, pharmacy-grade path cannot. pru only does that path.
What happened to Strate Labs
The verified facts are narrow. Strate Labs, a research-use-only peptide vendor, posted a sitewide notice on stratelabs.com that it is closing in 2026, with clearance discounts across its catalog. Its statement cited a regulatory landscape that shifted in ways that made it impossible to keep operating with its prior quality, transparency, and integrity. That is the reason the company itself gave, in its own words, rather than an outside interpretation.
The regulatory record around Strate Labs is documented. Strate Labs was a named respondent in Eli Lilly's 2023 U.S. International Trade Commission complaint over imported tirzepatide. It was found in default in May 2024 and was subject to a cease-and-desist. Those are matters of record in the ITC proceeding, not allegations made here.
The closure also sits within a broader shift. Through 2025 and 2026 there has been an enforcement wave against research-use-only peptide vendors, spanning FDA warning letters and import alerts, Department of Justice actions, and brand lawsuits. Strate Labs framed its own decision to close as a response to a regulatory landscape that shifted underneath it.
WHAT THE RECORD SHOWSStrate Labs stated its own reason for closing: a shifted regulatory landscape it said made continued operation impossible on its prior terms. Separately, the ITC record shows it was a named respondent in Eli Lilly's 2023 complaint over imported tirzepatide, found in default in May 2024, and subject to a cease-and-desist.
The customer impact is the part that matters most if you are reading this. When a research-use-only vendor closes, buyers are left with no source, and there is no prescriber to call, no licensed pharmacy on the hook, and no accountable party to move them onto anything else.
Why this happens to research-use-only vendors
A closure like this is not a freak event. It is the built-in risk of the research-use-only model. A research-use-only vendor sells vials labeled for laboratory research only, which is how it stays outside the rules that apply to anything meant to go into a person.
That same structure is what leaves it exposed. When there is no prescriber, no licensed pharmacy, and no regulated party standing behind the product, there is also no one obligated to keep serving you or answer for what was in the vial when enforcement pressure arrives.
- No prescriber. No licensed clinician reviewed your history or is responsible for your care, so no one is obligated to keep it going.
- No licensed pharmacy. No 503A or 503B facility, no pharmacist oversight, and no dispensing record tied to you.
- Exposed to enforcement. The 2025-2026 wave of FDA warning letters and import alerts, Department of Justice actions, and brand lawsuits falls hardest on exactly this model, as the Strate Labs closure shows.
- No recourse when it ends. No transferable prescription and no regulated party to move you onto a legitimate path. When the site goes dark, your source goes with it.
THE LESSONThe peptides may be real, but the vendor is fragile by design. A research-use-only seller with no prescriber, no licensed pharmacy, and no accountability can be forced to close, taking your source with it.
The durable, accountable, legal, verified alternative keeps the peptides but replaces the fragile part. For more on the two tiers, see pharmacy-grade vs grey-market peptides and research-grade vs pharmacy-grade peptides.
The safe pharmacy-grade alternative
The safe alternative is pharmacy-grade. A licensed physician prescribes, an FDA-registered 503A pharmacy compounds the peptide for you as an individual, a Certificate of Analysis verifies each batch, and, with pru, the peptide is priced at cost. Every part that a research-use-only vendor skips is added back, and every part that leaves a research-use-only vendor exposed is replaced with an accountable, regulated one. Here is the contrast, line by line.
| What matters | A research-use-only vendor | pru (pharmacy-grade) |
|---|---|---|
| Can it be forced to close? | Yes; a vendor outside the rules can be pushed out by enforcement, as Strate Labs was when it announced its 2026 closing | No; pru is an accountable, LegitScript-certified telehealth and pharmacy path built to operate within the rules |
| Prescriber | None; no clinician at any step | Licensed U.S. physician confirms the peptide is appropriate for you, or advises against it |
| Who fills it | Research-chemical supplier; no pharmacy in the chain | FDA-registered 503A compounding pharmacy |
| Testing | Seller-attested at best; no independent chain of custody tied to your order | A Certificate of Analysis verifies every batch |
| If something goes wrong | No recourse and no accountable party | A licensed provider and pharmacy stand behind every fill |
| Pricing | Per-vial retail on a research chemical | Peptides at cost, itemized, plus a separate $50/mo membership (billed annually) |
The trade is clear. A research-use-only vendor gives you a vial and a disclaimer, and it can be gone tomorrow. pru gives you a prescriber, a licensed pharmacy, a batch-verified fill, and at-cost pricing you can read line by line, from a provider that stays accountable. When you start on a 3-month plan, pru's compounded semaglutide comes to about $60 a month and tirzepatide to about $93 a month, because the medication is priced at cost with no markup.
Membership is separate: $50 a month billed annually for unlimited at-cost access, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. To vet any provider yourself, see how to verify a peptide source and where to buy peptides safely online.
How pru works, at cost
pru is a LegitScript-certified DTC membership telehealth platform built only for compounded peptides. pru's content guides you to the peptide that fits your goal and you choose it, a licensed physician confirms it is appropriate for you (or advises against it) and sets the dose, an FDA-registered 503A pharmacy compounds and fills it with a Certificate of Analysis, and the peptide is priced at cost, itemized, with no markup on the medicine.
When you start on a 3-month plan, your price for compounded semaglutide comes to about $60 a month (about $93 a month for tirzepatide), the lowest, because the medication is at cost.
Membership is separate: $50 a month billed annually for unlimited access to the platform and clinician messaging, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. pru offers compounded peptides, including semaglutide, tirzepatide, NAD+, glutathione, sermorelin, GHK-Cu cream, PT-141 nasal spray, and oxytocin, as injection, nasal spray, or GHK-Cu cream. pru does not sell research-grade material.
Browse everything available now in the full catalog, or see the at-cost pricing. If you were buying for weight care, the weight loss & metabolism category has the GLP-1 options; for NAD+ and longevity, see cellular health. Losing a supplier is a hard way to learn the lesson, but it is the moment to be proactive about your health and move onto a prescribed, tested path that stays accountable to you. Take the next step whenever you are ready.
WHERE PRU SITSpru works only in the prescribed, pharmacy-grade tier: individualized, 503A-compounded peptides documented with a Certificate of Analysis. Pharmacy-grade means a physician prescribed it and a licensed pharmacy made it. It does not mean FDA-approved.
Related reading
- Peptide Vendor Shutdowns in 2026
- Pharmacy-Grade vs Grey-Market Peptides
- Research-Grade Peptide Alternatives
- How to Verify a Peptide Source
- Where to Buy Peptides Safely Online
- Are Compounded Peptides Safe?
Common questions
Sources & further reading
- Strate Labs closure notice on stratelabs.com (sitewide notice of closing in 2026; clearance discounts across catalog; company statement citing a regulatory landscape that shifted in ways that made it impossible to keep operating with its prior quality, transparency, and integrity). Accessed July 2026.
- U.S. International Trade Commission record, Eli Lilly complaint over imported tirzepatide (Strate Labs named respondent, 2023; found in default May 2024; subject to a cease-and-desist). Accessed July 2026.
- Reporting on the 2025-2026 enforcement wave against research-use-only peptide vendors (FDA warning letters and import alerts, Department of Justice actions, and brand lawsuits). Accessed July 2026.
- U.S. Food and Drug Administration. Human Drug Compounding and Compounding and the FDA: Questions and Answers (503A; compounded drugs are not FDA-approved). fda.gov. Accessed July 2026.
- pru catalog, category, and pricing pages. joinpru.com. Accessed July 2026.
- Compounded peptide pricing (internal pru research): pru compounded semaglutide medication approx. $60/mo and tirzepatide approx. $93/mo on a 3-month starter plan, priced at cost, with a separate $50/mo membership (billed annually, unlimited at-cost access). Accessed July 2026.
- LegitScript. Healthcare Merchant Certification. legitscript.com. Accessed July 2026.